Global burden of cardiovascular disease attributable to smoking, 1990–2019: an analysis of the 2019 Global Burden of Disease Study
European Journal of Preventive Cardiology · 2024
DOI: 10.1093/eurjpc/zwae040 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Preventive Cardiology, 2024. Verfasst von Abdul Mannan Khan Minhas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Global Burden of Disease, Smoking. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Aims
This study aims to investigate the trends in the global cardiovascular disease (CVD) burden attributable to smoking from 1990 to 2019. Methods and results Global Burden of Disease Study 2019 was used to analyse the burden of CVD attributable to smoking (i.e. ischaemic heart disease, peripheral artery disease, stroke, atrial fibrillation and flutter, and aortic aneurysm). Age-standardized mortality rates (ASMRs) per 100 000 and age-standardized disability-adjusted life year rates (ASDRs) per 100 000, as well as an estimated annual percentage change (EAPC) in ASMR and ASDR, were determined by age, sex, year, socio-demographic index (SDI), regions, and countries or territories. The global ASMR of smoking-attributed CVD decreased from 57.16/100 000 [95% uncertainty interval (UI) 54.46–59.97] in 1990 to 33.03/100 000 (95% UI 30.43–35.51) in 2019 [EAPC −0.42 (95% UI −0.47 to −0.38)]. Similarly, the ASDR of smoking-attributed CVD decreased between 1990 and 2019. All CVD subcategories showed a decline in death burden between 1990 and 2019. The burden of smoking-attributed CVD was higher in men than in women. Significant geographic and regional variations existed such that Eastern Europe had the highest ASMR and Andean Latin America had the lowest ASMR in 2019. In 2019, the ASMR of smoking-attributed CVD was lowest in high SDI regions.
Conclusion
Smoking-attributed CVD morbidity and mortality are declining globally, but significant variation persists, indicating a need for targeted interventions to reduce smoking-related CVD burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA.
- Division of Cardiology, Loma Linda University Medical Center, Loma Linda, 2068 Orange Tree Lane, Suite 215, Redlands, CA 92374, USA.
- Department of Cardiology, Medstar Heart and Vascular Institute, Silver Springs, MD, USA.
- Section on Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Department of Cardiology, Westchester Medical Center, Valhalla, NY, USA.
- Section of Cardiology, Baylor College of Medicine, Houston, TX, USA.
ORCID-Profile: Ramy Sedhom, Dmitry Abramov
Zitieren
APA
Khan Minhas, A. M., Sedhom, R., Jean, E. D., Shapiro, M. D., Panza, J. A., Alam, M., Virani, S. S., Ballantyne, C. M., & Abramov, D. (2024). Global burden of cardiovascular disease attributable to smoking, 1990–2019: an analysis of the 2019 Global Burden of Disease Study. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwae040
Vancouver
Khan Minhas AM, Sedhom R, Jean ED, Shapiro MD, Panza JA, Alam M, et al. Global burden of cardiovascular disease attributable to smoking, 1990–2019: an analysis of the 2019 Global Burden of Disease Study. European Journal of Preventive Cardiology. 2024. doi:10.1093/eurjpc/zwae040
BibTeX
@article{KhanMinhas2024,
author = {Khan Minhas, Abdul Mannan and Sedhom, Ramy and Jean, Estelle D and Shapiro, Michael D and Panza, Julio A and Alam, Mahboob and Virani, Salim S and Ballantyne, Christie M and Abramov, Dmitry},
title = {Global burden of cardiovascular disease attributable to smoking, 1990–2019: an analysis of the 2019 Global Burden of Disease Study},
journal = {European Journal of Preventive Cardiology},
year = {2024},
doi = {10.1093/eurjpc/zwae040}
}
EUVIMED